<DOC>
	<DOCNO>NCT02601222</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Runzao zhiyang capsule treat chronic eczema .</brief_summary>
	<brief_title>Efficacy Safety Runzao Zhiyang Capsule Treat Chronic Eczema</brief_title>
	<detailed_description>Polygoni multiflori Preparata , dry rehmannia root , mulberry leaf , sophora flavescens , Honghuoma , skin itching , acne , constipation due blood vacuity wind-dryness , also use clinical treatment eczema . The purpose study evaluate efficacy safety Runzao zhiyang capsule treat chronic eczema .</detailed_description>
	<mesh_term>Eczema</mesh_term>
	<criteria>Consistent diagnostic criterion chronic eczema ( Referring `` Chinese eczema diagnosis treatment guideline '' 2011 ) ; Investigator Global Assessment ( IGA ) score 2 3 ; The skin lesion localize , hypertrophy dry , affect skin area 3 % ~10 % body surface area ( estimate palm method ) ; diameter target lesion 2~10cm locate limb trunk . The course chronic eczema 6 month ; Age 18 70 , male female ; The Subjects obtain informed consent , participate trial voluntarily . Procedure obtain informed consent accordance provision Good Clinical Practise ( GCP ) . Subjects acute eczema , subacute eczema , universal eczema , special type eczema ; Subjects use corticosteroid , immunosuppressive agent ultraviolet irradiation 4 week prior enrollment ; Subjects treat antihistamine topical drug 2 week ; Women Pregnancy , Lactation , Planned pregnancy test ; Comorbid severe primary heart , liver , lung , kidney , blood disease , diabetes , thyroid disease serious disease affect survival , cancer HIV / AIDS ; Subjects allergic test drug ingredient ; Subjects could give full inform consent mental behavioral disorder ; Suspected identified history alcohol drug abuse ; Have disease condition may reduce possibility enrollment complicate recruit process base investigator judgment . For example , work environment change frequently lead easily lose followup ; Have currently enrol clinical trial within 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>chronic eczema</keyword>
	<keyword>efficacy safety</keyword>
	<keyword>Runzao zhiyang capsule</keyword>
</DOC>